These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20944110)

  • 21. Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway.
    Yang H; Fan S; An Y; Wang X; Pan Y; Xiaokaiti Y; Duan J; Li X; Tie L; Ye M; Li X
    Oncotarget; 2016 Dec; 7(50):83641-83656. PubMed ID: 27845899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.
    Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K
    Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells.
    Wang Y; Kuramitsu Y; Baron B; Kitagawa T; Tokuda K; Akada J; Maehara SI; Maehara Y; Nakamura K
    Int J Oncol; 2017 Feb; 50(2):606-612. PubMed ID: 28000865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired resistance to gemcitabine and cross-resistance in human pancreatic cancer clones.
    Yoneyama H; Takizawa-Hashimoto A; Takeuchi O; Watanabe Y; Atsuda K; Asanuma F; Yamada Y; Suzuki Y
    Anticancer Drugs; 2015 Jan; 26(1):90-100. PubMed ID: 25187316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells.
    Maehara S; Tanaka S; Shimada M; Shirabe K; Saito Y; Takahashi K; Maehara Y
    Int J Cancer; 2004 Nov; 112(2):184-9. PubMed ID: 15352029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action.
    Baron B; Wang Y; Maehara S; Maehara Y; Kuramitsu Y; Nakamura K
    Anticancer Res; 2015 Apr; 35(4):1941-9. PubMed ID: 25862846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
    Zou J; Su H; Zou C; Liang X; Fei Z
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines.
    Forika G; Kiss E; Petovari G; Danko T; Gellert AB; Krenacs T
    Pathol Oncol Res; 2021; 27():1610048. PubMed ID: 34955688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer.
    Fang Y; Zhou W; Rong Y; Kuang T; Xu X; Wu W; Wang D; Lou W
    Exp Cell Res; 2019 Oct; 383(1):111543. PubMed ID: 31374207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment.
    Baron B; Kitagawa T; Nakamura K; Kuramitsu Y
    Cancer Genomics Proteomics; 2015; 12(2):49-55. PubMed ID: 25770187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells.
    Gong J; Muñoz AR; Pingali S; Payton-Stewart F; Chan DE; Freeman JW; Ghosh R; Kumar AP
    Mol Carcinog; 2017 Feb; 56(2):402-411. PubMed ID: 27208550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil.
    Kurata N; Fujita H; Ohuchida K; Mizumoto K; Mahawithitwong P; Sakai H; Onimaru M; Manabe T; Ohtsuka T; Tanaka M
    Int J Oncol; 2011 Aug; 39(2):473-82. PubMed ID: 21617862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
    Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
    Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
    Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer.
    Ma G; Sun Y; Fu S
    Int J Clin Exp Pathol; 2015; 8(10):13284-8. PubMed ID: 26722531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells.
    Kuramitsu Y; Wang Y; Taba K; Suenaga S; Ryozawa S; Kaino S; Sakaida I; Nakamura K
    Anticancer Res; 2012 Jun; 32(6):2295-9. PubMed ID: 22641665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer.
    Liu QH; Yong HM; Zhuang QX; Zhang XP; Hou PF; Chen YS; Zhu MH; Bai J
    Invest New Drugs; 2020 Apr; 38(2):350-359. PubMed ID: 31124054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
    Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer.
    Qu Y; Yang Y; Liu B; Xiao W
    Med Oncol; 2010 Dec; 27(4):1303-8. PubMed ID: 20012234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.